Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Provenge extends prostate cancer survival by about 4 months.

There is no link between hair loss and prostate enlargement.

Shift work disrupts the body's natural clock, leading to health problems.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Feeling younger can improve health and extend life.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

Finasteride may cause depression and suicidal thoughts, especially in young men.

Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Biofield Energy Treatment, specifically The Trivedi Effect®, can potentially enhance hair growth by increasing the growth activity of human dermal papilla cells.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Finasteride may worsen infertility in men with existing issues, but stopping it can improve sperm health.

Finasteride improves prostate cancer detection in PSA test.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

The May issue discussed publishing agreements and four studies on cholesterol in hair, cancer cell changes, hormones in the uterus, and skin protein effects.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.